Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer.
Jacques Mauillon(Université Le Havre Normandie), Thierry Frébourg(Inserm), Jean‐Baptiste Latouche(Inserm), J Métayer, B Paillot(Centre Henri Becquerel), Viviane Moreau, F. Charbonnier(Universidad Autónoma de Nuevo León), Jean‐Marc Limacher(Transgene (France)), Cosette Martin, Pierre Déchelotte(Inserm)
PubMed
December 15, 1996
Cited by 78
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Prevalence of eating disorders over the 2000–2018 period: a systematic literature review
|American Journal of Clinical Nutrition|2018|1.7k
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
|Immunity|2016|1.1k
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766